After moving -3.4% during today's afternoon session, Intuitive Surgical is now trading at a price of $297.33 per share. On average, analysts give it a target price of $367.95.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Intuitive Surgical Investors Should Consider This:
-
Intuitive Surgical has moved 38.0% over the last year.
-
The company has a price to earnings growth (PEG) ratio of 3.5. A number between 0 and 1 could mean that the market is undervaluing Intuitive Surgical's estimated growth potential
-
Its Price to Book (P/B) ratio is 8.79
Understanding Intuitive Surgical's Operating Margins
| Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-10 | 6,222,200 | -2,618,900 | 25 | -21.88 |
| 2022-02-03 | 5,710,100 | -2,137,500 | 32 | 33.33 |
| 2021-02-10 | 4,358,400 | -1,811,400 | 24 | -22.58 |
| 2020-02-07 | 4,478,500 | -1,735,700 | 31 | -3.12 |
| 2019-02-04 | 3,724,200 | -1,404,700 | 32 | -5.88 |
| 2018-02-02 | 3,138,200 | -1,139,100 | 34 |
Intuitive Surgical's operating margins have averaged 29.7% over the last 6 years, which is significantly higher than the Medical Instruments & Supplies industry average of 15.02%. The firm's margins exhibit a relatively stable growth trend of -4.8%.
